Following 14 years of collaboration between international societies and patient groups spanning six continents, polycystic ovary syndrome (PCOS) has now been renamed polyendocrine metabolic ovarian syndrome (PMOS).
The renaming was spearheaded by the endocrinologist Profeossor Helena Teede, the director of Melbourne’s Monash Centre for Health Research and Implementation and she joins me now
